Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy

Surgery

Volumn 137, Issue 5, 2005, Pages 536-544

  Doki, Yuichiro ^a   Takachi, Ko ^a   Ishikawa, Osamu ^a   Sasaki, Yo ^a   Miyashiro, Isao ^a   Ohigashi, Hiroaki ^a   Yano, Masahiko ^a   Ishihara, Ryu ^a   Tsukamoto, Yoshitane ^a   Nishiyama, Kinji ^a   Ishiguro, Shingo ^a   Imaoka, Shingi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS ULCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY; TREATMENT FAILURE; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 20944443284     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.01.008     Document Type: Article

References (35)

1. B.D. Minsky, T.F. Pajak, R.J. Ginsberg, T.M. Pisansky, J. Martenson, and R. Komaki INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
2. S. Hironaka, A. Ohtsu, N. Boku, M. Muto, F. Nagashima, and H. Saito Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 57 2003 425 433
3. A. Chan, and A. Wong Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 45 1999 265 270
4. J.D. Urschel, and F.W. Sellke Complications of salvage esophagectomy Med Sci Monit 9 2003 RA173 RA180
5. S.G. Swisher, P. Wynn, J.B. Putnam, M.B. Mosheim, A.M. Correa, and R.R. Komaki Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy J Thorac Cardiovasc Surg 123 2002 175 183
6. H.J. Stein, H. Bartels, and J.R. Siewert Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients Chirurg 72 2001 881 886
7. M. Sakuraba, Y. Kimata, S. Hishinuma, M. Nishimura, N. Gotohda, and S. Ebihara Importance of additional microvascular anastomosis in esophageal reconstruction after salvage esophagectomy Plast Reconstr Surg 113 2004 1934 1939
8. M. Yamamoto, Y. Doki, H. Shiozaki, M. Yano, H. Miyata, and S. Tamura Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens Dis Esophagus 13 2000 293 300
9. Q. Yang, K.R. Cleary, J.C. Yao, S.G. Swisher, J.A. Roth, and P.M. Lynch Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen Dis Esophagus 17 2004 38 43
10. M. Weinmann, C. Belka, and L. Plasswilm Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours Onkologie 27 2004 83 90
11. N.C. Denko, L.A. Fontana, K.M. Hudson, P.D. Sutphin, S. Raychaudhuri, and R. Altman Investigating hypoxic tumor physiology through gene expression patterns Oncogene 22 2003 5907 5914
12. C.A. Perez, L.W. Brady, E.C. Halperin, and R.K. Schmidt-Ullrich Principles and practice of radiation oncology 4th ed 2003 Lippincott-Raven Publishers New York
13. B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, and G. Ferreira Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1 Cancer Res 63 2003 1138 1143
14. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, and P.M. Comoglio Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 2003 347 361
15. A. Ohtsu, N. Boku, K. Muro, K. Chin, M. Muto, and S. Yoshida Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 1999 2915 2921
16. M. Yano, T. Tsujinaka, H. Shiozaki, M. Inoue, Y. Doki, and M. Yamamoto Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus J Surg Oncol 70 1999 25 32
17. L.H. Sobin, and C. Wittekind TNM classification of malignant tumours 6th ed. 2002 John Wiley and Sons, Inc New York
18. Y. Doki, O. Ishikawa, T. Kabuto, M. Hiratsuka, Y. Sasaki, and H. Ohigashi Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach Surgery 133 2003 479 485
19. Y. Doki, T. Kabuto, O. Ishikawa, H. Ohigashi, Y. Sasaki, and T. Yamada Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer? Surgery 130 2001 792 797
20. T. Kabuto, T. Yasuda, H. Furukawa, M. Higashiyama, K. Takami, and H. Yokouchi Combined resection of the aorta for an esophageal carcinoma invading the aorta through a right transthoracic approach Jpn J Thorac Cardiovasc Surg 47 1999 611 616
21. T. Yasuda, T. Kabuto, S. Ishiguro, H. Nakano, S. Nakamori, and H. Ohigashi Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus Gan To Kagaku Ryoho 22 1995 1538 1541
22. H. Kato, T. Miyazaki, M. Yoshikawa, M. Nakajima, Y. Fukai, and N. Masuda Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma Anticancer Res 21 2001 3323 3329
23. H. Kato, J. Takita, T. Miyazaki, M. Nakajima, Y. Fukai, and N. Masuda Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma Anticancer Res 23 2003 3263 3272
24. H. Miyata, Y. Doki, H. Shiozaki, M. Inoue, M. Yano, and Y. Fujiwara CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers Clin Cancer Res 6 2000 4859 4865
25. K. Kishi, Y. Doki, H. Miyata, M. Yano, T. Yasuda, and M. Monden Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer Br J Surg 89 2002 597 603
26. H. Takeuchi, S. Ozawa, N. Ando, Y. Kitagawa, M. Ueda, and M. Kitajima Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus Ann Surg Oncol 10 2003 792 800
27. M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, and A. Haimovitz-Friedman Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
28. H.J. Mauceri, N.N. Hanna, M.A. Beckett, D.H. Gorski, M.J. Staba, and K.A. Stellato Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
29. S. Hironaka, T. Hasebe, T. Kamijo, A. Ohtsu, N. Boku, and S. Yoshida Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy Clin Cancer Res 8 2002 124 130
30. R.E. Airley, J. Loncaster, J.A. Raleigh, A.L. Harris, S.E. Davidson, and R.D. Hunter GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding Int J Cancer 104 2003 85 91
31. M. Sohda, H. Ishikawa, N. Masuda, H. Kato, T. Miyazaki, and M. Nakajima Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer Int J Cancer 110 2004 838 844
32. H.A. Wieder, B.L. Brucher, F. Zimmermann, K. Becker, F. Lordick, and A. Beer Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908
33. T. Imai, A. Horiuchi, C. Wang, K. Oka, S. Ohira, and T. Nikaido Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells Am J Pathol 163 2003 1437 1447
34. J. Okami, D.M. Simeone, and C.D. Logsdon Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer Cancer Res 64 2004 5338 5346
35. A. Imdahl, J. Jenkner, C. Ihling, K. Ruckauer, and E.H. Farthmann Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer? Am J Surg 179 2000 514 520